Abstract
Phage therapy has recently been revitalized in the West with many successful applications against multi-drug-resistant bacterial infections. However, the lack of geographically diverse bacteriophage (phage) genomes has constrained our understanding of phage diversity and its genetics underpinning host specificity, lytic capability, and phage-bacteria co-evolution. This study aims to locally isolate virulent phages against uropathogenic Escherichia coli (E. coli) and study its phenotypic and genomic features. Three obligately virulent Escherichia phages (øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003) that could infect uropathogenic E. coli were isolated and characterized. All three phages belonged to Krischvirus genus. One-step growth curve showed that the latent period of the phages ranged from 15 to 20 min, the outbreak period ~ 50 min, and the burst size ranged between 74 and 127 PFU/bacterium. Moreover, the phages could tolerate a pH range of 6 to 9 and a temperature range of 25–37 °C for up to 180 min without significant loss of phage viability. All phages showed a broad host spectrum and could lyse up to 30% of the 35 tested E. coli isolates. Genomes of all phages were approximately ~ 163 kb with a gene density of 1.73 gene/kbp and an average gene length of ~ 951 bp. The coding density in all phages was approximately 95%. Putative lysin, holin, endolysin, and spanin genes were found in the genomes of all three phages. All phages were strictly virulent with functional lysis modules and lacked any known virulence or toxin genes and antimicrobial resistance genes. Pre-clinical experimental and genomic analysis suggest these phages may be suitable candidates for therapeutic applications.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The World Health Organization (WHO) has identified carbapenem-resistant Escherichia coli (E. coli) as a critical pathogen, underscoring the need to prioritize research and development of novel antimicrobial agents to combat these pathogens. E. coli, a Gram-negative bacterium, is a typical member of the gastrointestinal tract’s normal flora in humans and animals. However, it can act as an opportunistic pathogen, leading to various infections, including intestinal diarrhea, urinary tract infections (UTIs), septicemia, and pneumonia (Murray et al. 2022). As such, understanding the mechanisms of antimicrobial resistance in E. coli and developing effective strategies to address its impact on public health is of utmost importance (Kaper et al. 2004). In recent years, treatment of such infections has become complicated due to the resistance towards most available antibiotics, including third- and fourth-generation cephalosporins and even colistin, which is considered a last resort drug (Thaden et al. 2016; Sidjabat and Paterson 2015; Johura et al. 2020). Antibiotic resistance poses significant challenges in developing countries due to lax adherence to treatment protocols, inadequate regulation of prescription drugs, unauthorized access to antibiotics, and excessive usage of antibiotics in livestock for financial gain (Ayukekbong et al. 2017).
Among various alternatives to antibiotics being explored, like the use of antimicrobial peptides (AMP), nanoparticles, and preventive probiotics, bacteriophage therapy (phage therapy) has been gaining renewed attention in the West due to its successful application against antibiotic-resistant bacterial infections (Ghosh et al. 2019; Feizi et al. 2022; Schmidt 2019). Bacteriophage (phage) is a virus that primarily infects bacteria and is assumed to be the most abundant biological entity in the biosphere of the earth (Cobian Guemes et al. 2016). Phages were used to treat bacterial infections before the discovery of antibiotics in the 1940s (Aswani and Shukla 2021). The rigor of phage-based research and its clinical application persisted in Eastern Europe like Poland, the former Soviet Republic of Georgia, and Russia (Wittebole, De Roock and Opal 2014). Phages therapy is effectively used to treat antimicrobial resistance (AMR) bacteria like methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (Ormälä and Jalasvuori 2013; Xu et al. 2015).
Phages from different natural environments may conserve genetic identity and diversity regardless of their host (Hambly and Suttle 2005). The complete sequence of the phage genome facilitates studies of phage ecology, evolution, biodiversity and genetic novelty (Hatfull and Hendrix 2011). It plays an important role in advancing phage research and foundation of the phage repositories for future use (Cook et al. 2021). Large numbers of sequenced phage genomes have been deposited into public databases; however, some genomic orphans are still yet to be discovered. Furthermore, most of the well-studied phages were isolated and sequenced from the Western world, like the Americas, and Europe, but few phages that infect pathogenic E. coli strains from regions outside of Europe and the USA have been well characterized and studied at a molecular level. Moreover, only few phages that can kill pathogenic E. coli strains from Southeast Asia have been studied at a molecular level, although the burden of MDR, particularly carbapenem resistance, is high in this region.
This study provides insight into the genetic and biological diversity of E. coli phages via morphology and genome-based analysis. The present study provides information on the genome architecture, functional annotation, and sequence homology of three newly isolated phages (from the same environment) to each other and other phage genomes isolated elsewhere. Preclinical studies, including stability assays and sequence analysis, further indicate the phage’s lifestyle and its suitability for therapeutic applications by confirming the absence of virulence genes and AMR genes.
Materials and methods
Bacterial strains and media
Three carbapenem-resistant clinical isolates of uropathogenic E. coli (M1, M2, and M3) were obtained from the National Public Health Laboratory, Kathmandu (NPHL, Kathmandu), and used as host bacteria for isolation of lytic phages. Upon receiving, the carbapenem resistance was verified by the phenotypic EDTA disc synergy test and molecular confirmation through blaNDM and blaKPC gene sequencing (data not shown). Additional uncharacterized uropathogenic clinical isolates (N = 50, E. coli = 35, Klebsiella pneumoniae = 10, Pseudomonas aeruginosa = 5) and a standard laboratory strain (E. coli MG1655, from ATCC, Manassas, USA) were recovered from the glycerol stock maintained at Central Department of Biotechnology, Tribhuvan University, Nepal, and used only for host-range analysis. The bacteria were propagated in Luria–Bertani (LB) broth (HiMedia, India) at 37 °C.
Phage isolation and purification
Phages were isolated from the municipal wastewater canals collected from Kathmandu, Nepal, using a previously described double-layer agar assay (DLAA) (Nepal et al. 2022a). Briefly, the water samples were centrifuged at 3220 × g (Centrifuge 5810 R, Eppendorf, Hamburg, Germany) for 20 min at 4 °C, and the supernatant was filtered through a 0.22-μm pore size Whatman™ syringe filter (Sigma-Aldrich, Missouri, USA). One milliliter of the filtrate was mixed with 100 µl exponentially propagating host bacteria separately (McFarland = 1.0) and left at room temperature without shaking (5 min) for phage adsorption. Three-milliliter semisolid top-agar (tryptic soya agar (TSA), agar = 0.4%, stored at 50 °C, HiMedia, India) was added to the mixture, mixed well by swirling, and poured onto the surface of previously prepared bottom-agar (TSA, agar = 1.0%, HiMedia, India). The plates were left to solidify completely and incubated at 37 °C overnight. The next day, the plates were examined for the presence of plaques. For purification, a single isolated plaque was cut and dissolved in 1.0 mL of sodium chloride-magnesium sulfate (SM) buffer (10 mM Tris–HCl, 10 mM MgSO4·7H2O, 2% gelatin, and 100 mM NaCl, pH 7.5). The process was repeated three times to obtain a pure phage strain. Further, phages were purified by isopycnic cesium chloride (CsCl) density-gradient ultracentrifugation described previously (Beilstein and Dreiseikelmann 2006; Sambrook and Russell 2001). Briefly, 2.0 mL high titer phage (> 1012 PFU/ml) lysate was overlaid onto a three-step CsCl gradient containing 1.5 mL each of 1.6p, 1.5p, and 1.4p density CsCl in an ultracentrifuge tube (Beckman Coulter, California, USA). The tube was centrifuged at 45,000 rpm at 4 °C for 5 h in a Beckman L8-80 M Ultracentrifuge with Ti 70.1 fixed angle rotor (Beckman Coulter, California, USA). The phages were collected from the gray-white band that appeared in the tube and dialyzed overnight in SM buffer using a slide-A-Lyzer dialysis cassette (10,000 MWCO, Thermo Scientific, USA). The phage preparation was finally filtered through a 0.22-μm pore-size Whatman™ syringe filter (Sigma-Aldrich, Missouri, USA). The phage titer was determined by DLAA as mentioned earlier.
Transmission electron microscopy
The CsCl purified phage lysate was fixed with 2% paraformaldehyde and 2.5% glutaraldehyde. Ten microliter phage lysate was spread on a carbon-coated copper grid and negatively stained with 2% (w/v) uranyl acetate (pH 4.5). The copper grid was dried and examined under the FEI Tecnai T-12 transmission electron microscope (TEM) (FEI Company, Oregon, USA) at an accelerating voltage of 80 kV.
Host range analysis
Isolated phages were tested for their host range on 50 different multidrug-resistant clinical isolates and a standard laboratory E. coli MG1655 strain. Initially, spot assay was done to determine the host range of the phages as described previously (Kutter 2009). Based on the spot assay results, the lysis efficacy of the phages on bacterial strains was assessed by Efficiency of Plating (EoP) with modification. Briefly, 100 µl of an overnight culture of each isolate was mixed individually with 3.0 mL of semi-solid top agar (TSA, agar = 0.4%, temperature = 50 °C) and immediately poured onto bottom agar plates (TSA, agar = 1.0%, previously prepared). The top agar was allowed to solidify at room temperature. Then, 10.0 µl of tenfold serial dilutions of the phage lysate (108 PFU/mL) was spotted on the bacterial lawn and completely absorbed on the top agar. The plates were then incubated overnight at 37 °C. After incubation, the lowest titer of the phage that gave countable plaques was determined and double layer agar assay was done as described above. The number of plaques was counted in each bacterial strain. The EoP was determined by dividing the average number of plaques formed on the tested bacterial strain by the average number of plaques on the original host bacterium. The test was performed in triplicates.
Temperature and pH stability
The stability of isolated phages at different pH and temperatures was determined according to D’Andrea et al. (2017) with modification. Briefly, known phages lysate (1 × 108 PFU/ml) in SM buffer was adjusted to different pHs ranging from 2 to 12. Phage suspensions were incubated for 60 min at 37 °C and then titrated using a double-layer agar assay as described previously. For temperature stability, known phage lysate (1 × 108 PFU/ml) was aliquoted into the Eppendorf tube and incubated at 25 °C, 37 °C, 50 °C, 60 °C, and 70 °C for up to 180 min and titrated by DLAA. The data were analyzed under an ordinary one-way and two-way analysis of variance (ANOVA).
One-step growth curve and burst size determination
A one-step growth experiment of the phages was performed as described previously by Heineman and Bull (2007) with slight modifications. Briefly, 500 μl of overnight bacterial culture was added to 9.5 ml of LB broth and incubated at 37 °C (rpm = 200) until culture density reached 10e8 (OD600 = 0.5, ~ 1 h). Phage lysate was added (1 × 106, multiplicity of infection [MOI] = 0.001) and incubated at 37 °C for 5 min without shaking. A 100 μl of culture was then transferred to 10 ml of pre-warmed LB (37 °C, 1000 × dilution) for adsorption of phages to the host bacteria. At 5.5 and 6.5 min from the infection, 1 ml culture was transferred to different Eppendorf tubes and 20 μl of supernatant from both tubes was titrated for unabsorbed phage (T1). Then, 50 μl of chloroform was added, vortexed, and 20 μl was titrated again (T2). After this, aliquots of 1 ml were taken at intervals of 5 min for up to 80 min, treated with 50 μl of chloroform and the highest phage titer was noted (T3).
Phage DNA extraction, genome analysis and in silico safety evaluation
The genomic DNA (gDNA) of the phages øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 was extracted by using standard phenol–chloroform extraction method as described previously (Malke 1989). The phage gDNA concentrations and the quality check was carried out using a NanoDrop 8000 (NanoDrop Technologies Inc., USA). Whole-genome sequencing was performed by the Illumina Nextseq500 platform (Illumina, USA). The CLC Genomics Workbench 6.0 (Qiagen, USA) at default parameters (minimum contig length, 200; automatic word size, yes; perform scaffolding, yes; mismatch cost, 2; insertion cost, 3; deletion cost, 3; length fraction, 0.5; similarity fraction, 0.8) was used to assemble the genome. Phage genomes were annotated for coding DNA sequences (CDS), tRNA, tmRNA, CRISPRs, virulence factors (VFs), toxins, and antimicrobial resistance genes (ARGs) using Pharokka v1.2.0 (Bouras et al. 2022), with all CDS assigned to a functional category using PHROGs (Terzian et al. 2021) where available. A circular map of the annotated phage genome along with the GC skew (window = 500) and GC content (window = 10) was visualized in R Statistical Software (v4.2.2; R Core Team, 2021) using ‘circlize’ R package (Gu et al. 2014). The lifestyle, order, family, and host of the phages were also computationally predicted through PhageAI (Tynecki et al. 2020).
Genome comparison and phylogenetic analysis
Basic Local Alignment Search Tool (BLAST) online tool from the NCBI website (https://blast.ncbi.nlm.nih.gov/Blast.cgi) (Altschul et al. 1990) was used for comparative nucleotide homology estimation. The phylogenetic tree was constructed BLASTing the query sequence (Escherichia phage Ec_Makalu_001, NCBI accession = MN894885.1) against the NCBI Viruses database (taxid:10,239) using the ‘fast minimum evolution method’ (max seq difference = 0.75). Only the 50 most common phages were included in the phylogenetic analysis. The tree was further visualized using ‘ggtree’ R package (Yu et al. 2017). Also, the genome-based phylogeny and classification were carried out using a VICTOR web service (https://victor.dsmz.de) (Meier-Kolthoff et al., 2013). All pairwise comparisons of the nucleotide sequences were conducted using the Genome-BLAST Distance Phylogeny (GBDP) method under settings recommended for prokaryotic viruses (Meier-Kolthoff and Göker, 2017).
Data availability and statistical analysis
The genome sequence data are deposited in NCBI under BioProject accession PRJNA594990 and are publicly available through the following GenBank accession numbers: Escherichia phage Ec_Makalu_001 (MN894885), Escherichia phage Ec_Makalu_002 (MN709127), and Escherichia phage Ec_Makalu_003 (MN882349). All statistical analyses were performed using GraphPad Prism 9 (ver 9.5.) and differences with p < 0.05 were considered statistically significant. Additional support data generated in this research and all the raw metadata are available as supplementary data through FigShare: https://doi.org/10.6084/m9.figshare.21739154 (Nepal 2022).
Results
Phage isolation and morphological characterization
Three phages named as Escherichia phage Ec_Makalu_001, Escherichia phage Ec_Makalu_002, and Escherichia phage Ec_Makalu_003 (hereafter referred to as øEc_Makalu_001, øEc_Makalu_002, øEc_Makalu_003 respectively) were isolated using three different carbapenem-resistant uropathogenic E. coli as a host. All phages produced small, clear, non-halo, and round plaques measuring approximately 2–4 mm in diameter on the lawn of the host bacteria (Fig. 1a–c). TEM micrograph of the phage particles revealed that all three phages had icosahedral capsid (head), a long tail with contractile sheath, a baseplate, and tail fibers (Fig. 1d–f). According to latest ICTV guidelines (Virus Taxonomy: 2022 Release) (Turner et al. 2023), all phages belonged to the Straboviridae family of Caudoviricetes class (Table 1 and 2).
One-step growth curve and burst size determination
The one-step growth curve experiment was performed to determine the latent period and burst size of all phages. The latent period of 2 phages (øEc_Makalu_001 and øEc_Makalu_003) was 20 min, while øEc_Makalu_002 had a shorter latent period of 15 min (Fig. 2a). The growth of øEc_Makalu_002 and øEc_Makalu_003 reached its plateau at 50 min while the plateau of øEc_Makalu_001 was 55 min (Fig. 2a). The burst size was calculated based on the final titer of the phage and the number of infected bacterial cells. The average burst sizes of øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 were approximately 127, 74, and 120 phage particles per bacterium respectively (Fig. 2a).
pH and thermal stability
The stability of isolated phages in different pH was determined by incubating phage lysate in different pH (1–12) for 60 min. The phage viability was significantly unaffected within pH 6 to 9, while viability significantly decreased at pH 3–5 and 10–11. However, phage viability was completely inactivated below pH 2 and above pH 12 (Fig. 2b). Similarly, the thermal stability of isolated phages was determined by incubating the phage lysate at different temperatures (25 °C, 37 °C, 50 °C, 60 °C, and 70 °C) up to 180 min. The titer of all phages did not significantly decrease (p > 0.05) at 25 °C and 37 °C for up to 180 min while the phage titer decreased rapidly within 60 min when incubated at 50 °C and lost their viability completely after 180 min (Fig. 2c–e). The viability of phage decreased significantly at or above 60 °C within 30 min.
Host spectrum
Host range spectrum of øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 was evaluated using 50 different uropathogenic clinical isolates (35 E. coli, 10 K. pneumoniae, and 5 P. aeruginosa). Among the 3 phages, øEc_Makalu_001 lysed 28.5% (10/35) E. coli strains, while øEc_Makalu_002 and øEc_Makalu_003 could lyse 34.2% (12/35) E. coli strains as well as 20% (2/10) of the K. pneumoniae stains. No lytic activity against P. aeruginosa was observed among the three phages (Fig. 3). Further, EoP was performed to evaluate the ability of phages to produce plaque in bacterial strains other than their primary host. The EoP analysis revealed that the phages had low to high lysis ability (EoP range = 0.1 to 1) among all the spot test-positive E. coli strains. Phages øEc_Makalu_002 and øEc_Makalu_003 also showed inter-genus lysis activity in two of the K. pneumoniae isolates, but the plating efficiency was low (EoP = 0.0 to 0.2, Fig. 3). All three phages produced plaques on the laboratory strain of E. coli MG1655 (EoP = 0.9 to 1.0).
Genomic features
The genomes of øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 were composed of a linear double-stranded DNA of 163,752 bp (284 genes), 164,674 bp (285 genes), and 162,966 (284 genes) bp in length respectively. The GC content (~ 40.6%) and gene density (1.7 genes/kilo-base pairs) of all three phages were lower compared to its bacterial host E. coli (GC = ~ 50.6%, gene density = 0.5–1.0 gene/kilo-base pairs). The CDS coverage of all three phages was 95%, of which only approximately 40% of the CDS were annotated with known functions in all three phages. The rest of the genes were classified as having hypothetical functions. All three phage genomes lacked genes encoding known toxins, antimicrobial-resistance genes (ARGs), virulent factors (VFs) of bacterial origin, and phage lysogenic markers such as integrases, recombinases, repressor/anti-repressor proteins, and excisionases. Further, no tRNA, tmRNA, and CRISPRs were found (Table 1). Moreover, the in silico PhageAI tool (https://phage.ai/) categorized all three phages as strictly virulent (lytic) with high confidence (~ 96%). Hence, we consider all three phages to be excellent candidates for biocontrol of E. coli infections.
Based on the specific locations of the predicted genes, associated functions and overall organization of the genomes, typically comprising DNA packaging mechanism, GC content, DNA replication-transcription, and structural genes, all three phages shared a modular structure with many phages within the Straboviridae family (traditionally Myoviridae morphological family which is now abolished) (Turner et al. 2023), more specifically, with phages belonging to the genus of T4-like viruses with high similarity to the RB49 group virus (Petrov et al. 2010). Genes encoding putative holin, endolysin, and spanin complex (i-spanin/o-spanin) involved in the host bacteria lysis were scattered throughout the genomes of all three phages (Figs. 4, 5, 6). The average gene length in all three phages was highly similar and ranged between 546 and 551 base pairs (Fig. 7a). Compared to functional genes, the average lengths of hypothetical genes in all three phages were significantly lower (Fig. 7b, p < 0.001, t-test) suggesting them to be either non-functional false positives or part of the small-phage gene family noted recently by Fremin et al. (2022). Upon further analysis, we noticed that although almost 60% of the total genes were hypothetical (unknown function) in all three phages, the total nucleotide (genome) coverage by those hypothetical genes was lower (~ 29%) (Fig. 7c–d) indicating the hypothetical CDS to account for far lesser genome coverage than functional genes. Most of the phage genome encoded genes for DNA, RNA metabolism (~ 24%), and structural proteins like tail and tail fiber (~ 23%) followed by head and packaging (~ 7%) (Fig. 7d).
Comparative genome analysis and phylogeny
Further, comparative genome analysis of all three Escherichia phages revealed significant homology within each other and a high degree of nucleotide similarity (98%) (Fig. 7e and Table S1). Also, our phages were phylogenetically close to Enterobacteria phage Phi1 (query coverage = 96%, percent identity = 97.07%) (GenBank: EF437941). Further BLAST comparison of øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 with Enterobacteria phage Phi1 revealed that the essential structural genes, DNA replication, repair and recombination module, phage DNA packaging genes, and genes of auxiliary metabolism show a high level of nucleotide identity despite their different geographical origin (Fig. 7e). The genome of øEc_Makalu_001 shared 97% nucleotide similarity with both øEc_Makalu_002 and øEc_Makalu_003 and 93.19% with Enterobacteria phage Phi1. Similarly, øEc_Makalu_002 shared 96.1% identity with øEc_Makalu_003 and 91.2% with Enterobacteria phage Phi1. Ninety-one percent nucleotide identity was observed between øEc_Makalu_003 and Enterobacteria phage Phi1. Multiple genome alignment and progressive MAUVE comparison of isolated phages with each other revealed similar synteny and high homologous regions at protein levels, typically genes encoding DNA packaging/replication/transcription regulation, structural proteins like head, tail fiber, and lytic cassettes (Figs. 4–6 and Fig. S1).
MAUVE comparison of all 3 phages with the reference Enterobacteria phage Phi1 revealed that all these genomes are highly co-linear and related except for the deletion of seven genes of the Enterobacteria phage Phi1 (ORF84.1, ORF110, ORF111, ORF130.1, ORF131.1, ORF257, and ORF263.1) in the genomes of øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 phages. Likewise, hypothetical protein-coding genes, i.e., ORF 232, ORF237 of øEc_Makalu_001 homolog to ORF233, ORF238 of øEc_Makalu_002 and ORF233, ORF239 are absent in the genome of the Enterobacteria phage Phi1. Further, ORF238 of øEc_Makalu_001 and its homolog ORF240 of Enterobacteria phage Phi1 encoding a hypothetical protein is deleted in the genomes of øEc_Makalu_002 and øEc_Makalu_003. Interestingly, øEc_Makalu_002 genome possesses two alleles of HNH-type homing endonucleases (ORF131 and ORF240) which are absent in phage øEc_Makalu_001 and Enterobacteria phage Phi1, but only one HNH-type endonuclease (ORF136) is conserved in øEc_Makalu_003.
Further, a comparative phylogenetic analysis of our phage genomes in the NCBI nucleotide database (nBLAST) revealed that the phage genomes had substantial homology with 24 other phage genomes available in the NCBI database (coverage = 88–97%, identity = 93–98%, total identity = 84–97%) (Table S1) and distantly related to 3 Myoviridae sp. (partial genome, total identity = 19–21%) (Fig. 7f). All three phages (øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003), which were isolated from Kathmandu, Nepal, fall within the same family, genus, and species level clusters (F1, G1, and S6) (Fig. S3).
Discussion
The emergence of multi-drug-resistant organisms (MDROs), including E. coli, is becoming a public health threat. As such, there is a renewed interest in developing alternative strategies to combat the global burden of antibiotic resistance. Among many alternatives, phages and/or their components (lysin) are considered one of the potential and feasible alternatives, as phages are ubiquitous (Romero-Calle et al. 2019). Well-characterized phages are required for therapeutic use to ensure the genomic safety of the therapeutic phage as some lysogenic phages encode toxin-producing genes like Shiga toxin (stx) by Stx phages, cholera toxin (ctx) by CTX phages. Recently, AMR genes and other VFs have also been reported in transducing phages (prophages), which modulate bacterial lifestyle, virulence, and pathogenesis (Philipson et al. 2018; Nepal et al. 2022b, 2023). In the environment, the presence of phage depends upon the availability of their host bacterium. River water, sewage, soil, poultry manure, stagnant water, and sea water are rich sources of phages as they usually contain bacteria (Mulani et al. 2019). We primarily collected sewage from Kathmandu, Nepal, as a phage source because it is extensively contaminated with untreated waste from industries, hospitals, and households, creating a favorable niche for the dynamic co-evolution of phage and bacteria. This may equip phages with novel genetic backgrounds. As a result, a novel phage that is more effective against the pathogens in such a niche may evolve. Earlier, we isolated and studied the efficacy of virulent phages infecting Klebsiella pneumoniae and Pseudomonas aeruginosa (Dhungana et al. 2021a, 2021b; Maharjan et al. 2022). In this study, we isolated three phages, namely øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003, all belonging to Straboviridae family that could effectively lyse 28–34% of uropathogenic E. coli clinical isolates. All three phages produced clear plaques on their host lawn and were devoid of any ARGs, VFs, toxin-encoding genes, and lysogeny modules in their genomes. Thus, all three phages were considered strictly lytic, having potential for therapeutic applications.
Burst size (average number of phage particles released per infected bacterium) is an important parameter when selecting phages for efficient and effective phage therapy (Khan Mirzaei and Nilsson 2015). Our results revealed that the latent periods of the 3 phages were between 15 and 20 min, with a burst size of up to 127 phages/bacterium. The latent period, the time it takes for phage to induce the lysis of the host cell, depends on multiple factors like host physiology, and phage lytic protein complex like holin, endolysin, and spanin (Rajaure et al. 2015; Abedon et al. 2001). Phage having a short latent period (~ 20 min) and high burst size is better suited to eliminate infecting bacteria as well as overcome the risk of development of phage-resistant mutants. Here, all phages øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 showed promising lytic properties with short latent periods and with high burst sizes clearly showing potential for therapeutic applications.
The stability of phages in different physiochemical conditions is another important factor for storage and applications (Jonczyk et al. 2011). All phages used in this study were stable at 25 °C and 37 °C and between pH 6–9 without significant loss of phage titers. These results corroborate the findings of a great deal of previous work. Tailed phages (T4, T5, and T7) are known to be robust, survive in adverse conditions for several years, and thus are preferred in therapeutics (Ackermann et al. 2004). Previous studies have shown that tailed Myophage remained stable at 4–37 °C, decreased infectivity at 60–70 °C within 15 min, and was completely inactivated at 50 °C for 60 min or 80 °C for 15 min (Zhao et al. 2019). Similarly, T4 phage showed optimum stability at pH 6.0–7.4 and decreased its titer at above pH 9.2 and below pH 4.0 (Jonczyk et al. 2011). Our results agree with these findings and thus we conclude that our phages can be stored at optimum pH and temperatures without significant loss of its viability.
Further, the host range spectrum of a phage is critical in the selection of therapeutic phage and usually phages with a broad host range are preferred for therapeutic applications. Though phages are conventionally regarded as extremely specific to their host which limits their application in phage therapy, occasionally broad host range phages have been reported. Recent findings have shown that some phages possess the ability to infect a wide range of bacterial strains, including intergeneric lysis (Malki et al. 2015; Fernandez et al. 2019; Göller et al. 2021). Thus, the host range of isolated Escherichia phages was screened against isolates representing 3 different bacterial genera (Escherichia, Klebsiella, and Pseudomonas) followed by EoP to determine the relative EoP. Based on spot assay and EoP, all three phages showed broad host killing within its host genus Escherichia so were considered Wide Host Range (WHR) phages. Interestingly, øEc_Makalu_002 and øEc_Makalu_003 also showed intergeneric lysis producing faint lysis zone on the lawns of K. pneumoniae isolates (EoP = 0.0–0.2). This suggested property of polyvalent phages displaying remarkable host diversity by Myophages. Similar polyvalent WHR phages have also been reported in the past. Bielke et al. (2007) showed that lytic phage isolated using Salmonella enteritidis was also successfully amplified in Escherichia, Klebsiella, and other strains of Salmonella. Similarly, Sui et al. (2021) reported that polyvalent phage isolated using Escherichia coli could also infect Salmonella enteritidis and Jensen et al. (1998) reported phages capable of intergeneric replication in Sphaerotilus natans, E. coli, and P. aeruginosa that could cross-infect each other. Similarly, Greene and Goldberg (1985) were able to isolate bacteriophages capable of lysing more than one species of Streptomycetes. Further, a polyvalent Escherichia coli phage ECD7 (RB49 group of viruses) having WHR (infecting enterotoxigenic E. coli, enteroaggregative E. coli, enterohemorrhagic E. coli, Shigella flexneri, and Shigella sonnei) has been used as a phage-based probiotic dietary supplement to treat Traveler’s diarrhea (Aleshkin et al. 2015). In this study, we also report WHR phages able to infect distinct host genera. Based on this, we postulate that phages can interact with multiple host genera in nature and evolve over time, showing different phenotypic plasticity suggesting complex co-evolutionary relationships between bacteria and phages. In phage therapy, a phage that can infect multiple genera of bacteria effectively is equivalent to broad-spectrum antibiotics (Ross et al. 2016) and is an extremely desirable property because bacteriophages would not have to be isolated for individual isolates. This evidence suggests that WHR phages exist in nature, and a small library of such phages could potentially treat a wide range of infections. Additionally, the amplification of bacteriophages in a nonpathogenic alternative host eliminates the possibility of incorporating detrimental accessory genes during phage amplification. The low EoP on K. pneumoniae isolates might be due to the release of bacteriocin or breakdown of cellular energetics leading to abortive infection (Kutter 2009). Further analysis is required to characterize those phages and their intergenus infective capacity more in depth.
The long tail fiber of the phage initially recognizes the receptors present on the host cell surface and facilitates the initial binding, which determines host specificity (Hyman and van Raaij 2018). Comparative sequence analysis of tail fiber protein at the amino acid level using pairwise sequence alignment revealed that øEc_Makalu_002 and øEc_Makalu_003 shares 80.1% sequence similarity (Fig. S2). Both phages have highly conserved identical amino acid sequences (100% identical) in N-terminus (up to 371 residues) and low identity in the C-terminus region. N-terminal residues of the tail fiber protein are responsible for attachment towards the baseplate, so this region may be highly consistent while C-terminal region recognizes the host receptors protein where receptor-binding domain is located. Significant differences in host range and other biological properties could be observed with subtle changes in the sequence in tail fiber proteins (Yosef et al., 2017). The putative long-tail fiber tip protein of each phage is comparatively different from each other at a nucleotide level and may make different host range. It is further hypothesized that phages capable of intergeneric lysis may use receptors, intermediary functions, or both common to a wide range of bacteria to achieve a wide host range.
Computational analysis of the genomes revealed that all three phages were virulent and free from known toxins, ARGs and VFs of bacterial origin. Further, øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 genomes were highly homologous with the genomes of known members of T4-like viruses (representatives of the RB49 group, genus Krischvirus) (Walker et al. 2019). The RB49 group of viruses are pseudo-T-evens phages primarily infecting Enterobacteria and environmentally important as they are found ubiquitously (Monod et al. 1997) and till date, 19 phage genomes having more than 96% sequence identity with Enterobacteria phage RB49 have been deposited to NCBI GenBank. The genome size of all these phages ranged from 162,966 bp to 176,009 bp with a very small window of G + C content (40.32 to 40.68%) and were isolated using Escherichia coli as a primary host except two Shigella phages JK32 and Sf20. The genome size and G + C content of all 3 phages were also highly consistent with other phage genomes of RB49 group and shared > 96% ORF homology with each other. Interestingly, despite the phylogenetic relationship of the phages with each other and with other phages from RB49 group, they were isolated using different hosts and on different continents. A high degree of sequence similarity and identity may probably be due to the horizontal exchange of genes from a shared pool among the ancestors of contemporary phages during co-evolution (Hendrix et al. 1999). Thus, we assume that øEc_Makalu_001, øEc_Makalu_002, and øEc_Makalu_003 and their relatives may have co-evolved with their host through extensive gain, loss, and exchange of their genes under different selection pressures and diverged from a common ancestor. Homing endonucleases play an important role in homologous recombination between phages during co-infection with the same host. The variable number of HNH-type endonucleases found in the 3 phage genomes possibly have a role in the genome evolution of the phages. Further experiments are needed to unravel the exact role of these endonucleases and the significance in diversification and evolution of the phage genome over time.
Conclusions
In summary, all three isolated phages exhibited excellent anti-E. coli activities, high thermal and acid tolerance, fulfilled all the available essential genomic safety checkpoints for T4-like phage and qualified as a potential therapeutic phage candidate. All three phages shared conserved modular genome architecture similar to T4-like phages and shared a common ancestral sequence. Despite high sequence homology with each other, additional unique ORFs of unknown ortholog were identified within their genomes, possibly acquired by the mechanism of lateral gene transfer during evolution, as it is established that T4-like phages do not undergo lysogeny. This library would be valuable for selecting appropriate phage for future phage therapy, used alone or in phage cocktails, and future research work. Thus, regular isolation of phages from diverse ecology and geographical areas is necessary to understand their sequence diversity in phage databases.
Data availability
The original results of the study are included in the article. Additional data are included as supplementary data. Further inquiries can be directed to the corresponding author(s).
References
Abedon ST, Herschler TD, Stopar D (2001) Bacteriophage latent-period evolution as a response to resource availability. Appl Environ Microbiol 67:4233–4241
Ackermann HW (2001) Frequency of morphological phage descriptions in the year 2000. Adv Virol 146:843–857
Ackermann H-W, Tremblay D, Moineau SJWN (2004) Long-Term Bacteriophage Preservation 38:35–40
Aleshkin, A. V., E. O. Rubalskii, N. V. Volozhantsev, V. V. Verevkin, E. A. Svetoch, I. A. Kiseleva, S. S. Bochkareva, O. Y. Borisova, A. V. Popova, A. G. Bogun & S. S. Afanas’ev (2015) A small-scale experiment of using phage-based probiotic dietary supplement for prevention of E. coli traveler’s diarrhea. Bacteriophage, 5, e1074329.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Aswani VH, Shukla SK (2021) An early history of phage therapy in the United States: is it time to reconsider? Clin Med Res 19:82–89
Ayukekbong JA, Ntemgwa M, Atabe AN (2017) The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrob Resist Infect Control 6:47
Beilstein F, Dreiseikelmann B (2006) Bacteriophages of freshwater Brevundimonas vesicularis isolates. Res Microbiol 157:213–219
Bielke L, Higgins S, Donoghue A, Donoghue D, Hargis BM (2007) Salmonella host range of bacteriophages that infect multiple genera. Poult Sci 86:2536–2540
Bouras G, Nepal R, Houtak G, Psaltis AJ, Wormald P, Vreugde S (2022) Pharokka: A fast scalable bacteriophage annotation tool. Bioinform 39(1). https://doi.org/10.1093/bioinformatics/btac776
Cobian Guemes AG, Youle M, Cantu VA, Felts B, Nulton J, Rohwer F (2016) Viruses as winners in the game of life. Annu Rev Virol 3:197–214
Cook R, Brown N, Redgwell T, Rihtman B, Barnes M, Clokie M, Stekel DJ, Hobman J, Jones MA, Millard A (2021) INfrastructure for a PHAge REference Database: identification of large-scale biases in the current collection of cultured phage genomes. Phage (new Rochelle) 2:214–223
D’Andrea MM, Marmo P, Henrici De Angelis L, Palmieri M, Ciacci N, Di Lallo G, Dematte E, Vannuccini E, Lupetti P, Rossolini GM, Thaller MC (2017) phiBO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic Clonal Group 258 clade II lineage. Sci Rep 7:2614
Dhungana G, Malla R, Rajaure M, Adhya S (2020) Complete Genome Sequence of Myophage Ec_Makalu_002, Which Infects Uropathogenic Escherichia coli. Microbiol Resour Announc 9(5):10–1128. https://doi.org/10.1128/mra.01530-19
Dhungana G, Nepal R, Regmi M, Malla R (2021a) Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model. Front Cell Infect Microbiol 11:684704. https://doi.org/10.3389/fcimb.2021.684704
Dhungana G, Regmi M, Paudel P, Parajuli A, Upadhyay E, Gyawali I, Nepal R, Pradhan P, Malla R (2021b) Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model. J Nepal Health Res Counc 19(1):76–89. https://doi.org/10.33314/jnhrc.v19i1.3282
Feizi S, Cooksley CM, Nepal R, Psaltis AJ, Wormald P-J, Vreugde S (2022) Silver nanoparticles as a bioadjuvant of antibiotics against biofilm-mediated infections with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in chronic rhinosinusitis patients. Pathology 54:453–459
Fernández L, Gutiérrez D, García P, Rodríguez A (2019) The perfect bacteriophage for therapeutic applications—A quick guide. Antibiotics 8(3):126. https://doi.org/10.3390/antibiotics8030126
Fremin BJ, Bhatt AS, Kyrpides NC, Sengupta A, Sczyrba A, Maria Da Silva A, Buchan A, Gaudin A, Brune A, Hirsch AM, Neumann A, Shade A, Visel A, Campbell B, Baker B, Hedlund BP, Crump BC, Currie C, Kelly C, Craft C, Hazard C, Francis C, Schadt CW, Averill C, Mobilian C, Buckley D, Hunt D, Noguera D, Beck D, Valentine DL, Walsh D, Sumner D, Lymperopoulou D, Bhaya D, Bryant DA, Morrison E, Brodie E, Young E, Lilleskov E, Högfors-Rönnholm E, Chen F, Stewart F, Nicol GW, Teeling H, Beller HR, Dionisi H, Liao H-L, Beman JM, Stegen J, Tiedje J, Jansson J, Vandergheynst J, Norton J, Dangl J, Blanchard J, Bowen J, Macalady J, Pett-Ridge J, Rich J, Payet JP, Gladden JD, Raff JD, Klassen JL, Tarn J, Neufeld J, Gravuer K, Hofmockel K, Chen K-H, Konstantinidis K, Deangelis KM, Partida-Martinez LP, Meredith L, Chistoserdova L, Moran MA, Scarborough M, Schrenk M, Sullivan M, David M, O’Malley MA, Medina M, Habteselassie M, Ward ND, Pietrasiak N, Mason OU, Sorensen PO, P. Estrada De Los Santos, P. Baldrian, R. M. Mckay, R. Simister, R. Stepanauskas, R. Neumann, R. Malmstrom, R. Cavicchioli, R. Kelly, R. Hatzenpichler, R. Stocker, R. A. Cattolico, R. Ziels, R. Vilgalys, S. Blumer-Schuette, et al (2022) Thousands of small, novel genes predicted in global phage genomes. Cell Rep 39:110984
Ghosh C, Sarkar P, Issa R, Haldar J (2019) Alternatives to conventional antibiotics in the era of antimicrobial resistance. Trends Microbiol 27:323–338
Göller PC, Elsener T, Lorgé D, Radulovic N, Bernardi V, Naumann A, Amri N, Khatchatourova E, Coutinho FH, Loessner MJ, Gómez-Sanz E (2021) Multi-species host range of staphylococcal phages isolated from wastewater. Nat Commun 12:6965
Greene J, Goldberg RB (1985) Isolation and preliminary characterization of lytic and lysogenic phages with wide host range within the streptomycetes. Microbiology 131(9):2459–2465. https://doi.org/10.1099/00221287-131-9-2459
Gu Z, Gu L, Eils R, Schlesner M, Brors B (2014) circlize Implements and enhances circular visualization in R. Bioinformatics 30:2811–2812
Hambly E, Suttle CA (2005) The viriosphere, diversity, and genetic exchange within phage communities. Curr Opin Microbiol 8:444–450
Hatfull GF, Hendrix RW (2011) Bacteriophages and their genomes. Curr Opin Virol 1:298–303
Heineman RH, Bull JJ (2007) Testing optimality with experimental evolution: lysis time in a bacteriophage. Evolution 61:1695–1709
Hendrix RW, Smith MC, Burns RN, Ford ME, Hatfull GF (1999) Evolutionary relationships among diverse bacteriophages and prophages: all the world’s a phage. Proc Natl Acad Sci U S A 96:2192–2197
Hyman P, van Raaij M (2018) Bacteriophage T4 long tail fiber domains. Biophys Rev 10:463–471
Jensen EC, Schrader HS, Rieland B, Thompson TL, Lee KW, Nickerson KW, Kokjohn TA (1998) Prevalence of broad-host-range lytic bacteriophages of Sphaerotilus natans, Escherichia coli, and Pseudomonas aeruginosa. Appl Environ Microbiol 64:575–580
Johura FT, Tasnim J, Barman I, Biswas SR, Jubyda FT, Sultana M, George CM, Camilli A, Seed KD, Ahmed N, Alam M (2020) Colistin-resistant Escherichia coli carrying mcr-1 in food, water, hand rinse, and healthy human gut in Bangladesh. Gut Pathog 12:5
Jonczyk E, Klak M, Miedzybrodzki R, Gorski A (2011) The influence of external factors on bacteriophages–review. Folia Microbiol (praha) 56:191–200
Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140
Khan Mirzaei M, Nilsson AS (2015) Isolation of phages for phage therapy: a comparison of spot tests and efficiency of plating analyses for determination of host range and efficacy. PLoS ONE 10:e0118557
Kutter E (2009) Phage host range and efficiency of plating. Methods Mol Biol 501:141–149
Maharjan A, Nepal R, Dhungana G, Parajuli A, Regmi M, Upadhyaya E, Mandal D, Shrestha M, Pradhan P, Manandhar KD, Malla R (2022) Isolation and Characterization of Lytic Bacteriophage Against Multi-drug Resistant Pseudomonas aeruginosa. J Nepal Health Res Counc 19(04):717–724. https://doi.org/10.33314/jnhrc.v19i04.3837
Malke H (1989) J. SAMBROCK, E. F. FRITSCH and T. MANIATIS, Molecular Cloning, A Laboratory Manual (Second Edition), Volumes 1, 2 and 3. 1625 S., zahlreiche Abb. Und Tab. Cold Spring Harbor 1989. Cold Spring Harbor Laboratory Press. $ 115.00. ISBN: 0-87969-309-6. J Basic Microbiol 30(8):623. https://doi.org/10.1002/jobm.3620300824
Malki K, Kula A, Bruder K, Sible E, Hatzopoulos T, Steidel S, Watkins SC, Putonti C (2015) Bacteriophages isolated from Lake Michigan demonstrate broad host-range across several bacterial phyla. Virology Journal 12:164
Meier-Kolthoff JP, Auch AF, Klenk H-P, Göker M (2013) Genome sequence-based species delimitation with confidence intervals and improved distance functions. BMC Bioinform 14(1):60. https://doi.org/10.1186/1471-2105-14-60
Meier-Kolthoff JP, Göker M (2017) VICTOR: genome-based phylogeny and classification of prokaryotic viruses Abstract. Bioinformatics 33(21):3396–3404. https://doi.org/10.1093/bioinformatics/btx440
Monod C, Repoila F, Kutateladze M, Tetart F, Krisch HM (1997) The genome of the pseudo T-even bacteriophages, a diverse group that resembles T4. J Mol Biol 267:237–249
Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: A review. Front Microbiol 10. https://doi.org/10.3389/fmicb.2019.00539
Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, Johnson SC, Browne AJ, Chipeta MG, Fell F, Hackett S, Haines-Woodhouse G, Kashef Hamadani BH, Kumaran EAP, McManigal B, Achalapong S, Agarwal R, Akech S, Albertson S, Amuasi J, Andrews J, Aravkin A, Ashley E, Babin F-X, Bailey F, Baker S, Basnyat B, Bekker A, Bender R, Berkley JA, Bethou A, Bielicki J, Boonkasidecha S, Bukosia J, Carvalheiro C, Castañeda-Orjuela C, Chansamouth V, Chaurasia S, Chiurchiù S, Chowdhury F, Clotaire Donatien R, Cook AJ, Cooper B, Cressey TR, Criollo-Mora E, Cunningham M, Darboe S, Day NPJ, De Luca M, Dokova K, Dramowski A, Dunachie SJ, Duong Bich T, Eckmanns T, Eibach D, Emami A, Feasey N, Fisher-Pearson N, Forrest K, Garcia C, Garrett D, Gastmeier P, Giref AZ, Greer RC, Gupta V, Haller S, Haselbeck A, Hay SI, Holm M, Hopkins S, Hsia Y, Iregbu KC, Jacobs J, Jarovsky D, Javanmardi F, Jenney AWJ, Khorana M, Khusuwan S, Kissoon N, Kobeissi E, Kostyanev T, Krapp F, Krumkamp R, Kumar A, Kyu HH, Lim C, Lim K, Limmathurotsakul D, Loftus MJ, Lunn M, Ma J, Manoharan A, Marks F, May J, Mayxay M, Mturi N et al (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399:629–655
Nepal R, Houtak G, Wormald P-J, Psaltis AJ, Vreugde S (2022b) Prophage: a crucial catalyst in infectious disease modulation. The Lancet Microbe 3:e162–e163
Nepal R, Houtak G, Karki S, Dhungana G, Vreugde S, Malla R (2022a) Genomic characterization of three bacteriophages targeting multidrug resistant clinical isolates of Escherichia, Klebsiella and Salmonella. Arch Microbiol 204(6). https://doi.org/10.1007/s00203-022-02948-0
Nepal R, Houtak G, Bouras G, Ramezanpour M, Feizi S, Shaghayegh G, Shearwin K, Psaltis AJ, Wormald P-J, Vreugde S (2023). Prophage acquisition byStaphylococcus aureuscontributes to the expansion of Staphylococcal immune evasion. https://doi.org/10.1101/2023.04.27.538627
Nepal R (2022) Characterization and preclinical in silico safety assessment of three virulent bacteriophages targeting carbapenem-resistant uropathogenic Escherichia coli. figshare. Dataset. https://doi.org/10.6084/m9.figshare.21739154.v3
Ormälä AM, Jalasvuori M (2013) Phage therapy: Should bacterial resistance to phages be a concern, even in the long run? Bacteriophage 3:e24219
Petrov VM, Ratnayaka S, Nolan JM, Miller ES, Karam JD (2010) Genomes of the T4-related bacteriophages as windows on microbial genome evolution. Virol J 7:292
Philipson CW, Voegtly LJ, Lueder MR, Long KA, Rice GK, Frey KG, Biswas B, Cer RZ, Hamilton T, A., K. (2018) Characterizing Phage Genomes for Therapeutic Applications. Viruses 10(4):188. https://doi.org/10.3390/v10040188
Rajaure M, Berry J, Kongari R, Cahill J, Young R (2015) Membrane fusion during phage lysis. Proc Natl Acad Sci U S A 112:5497–5502
Romero-Calle D, Guimaraes Benevides R, Goes-Neto A, Billington C (2019) Bacteriophages as Alternatives to Antibiotics in Clinical Care. Antibiotics 8(3):138. https://doi.org/10.3390/antibiotics8030138
Ross A, Ward S, Hyman P (2016) More is better: selecting for broad host range bacteriophages. Front Microbiol 7:1352
Sambrook J, Russell DW, 1957- & Cold Spring Harbor Laboratory (2001). In: Sambrook J, Russell DW (eds) Molecular cloning : a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
Schmidt C (2019) Phage therapy’s latest makeover. Nat Biotechnol 37:581–586
Sidjabat HE, Paterson DL (2015) Multidrug-resistant Escherichia coli in Asia: epidemiology and management. Expert Rev Anti Infect Ther 13:575–591
Sui B, Han L, Ren H, Liu W, C. Zhang (2021) A Novel Polyvalent Bacteriophage vB_EcoM_swi3 Infects Pathogenic Escherichia coli and Salmonella enteritidis. Front Microbiol 12. https://doi.org/10.3389/fmicb.2021.649673
Terzian, P., E. Olo Ndela, C. Galiez, J. Lossouarn, Rubén E. Pérez Bucio, R. Mom, A. Toussaint, M.-A. Petit & F. Enault (2021) PHROG: families of prokaryotic virus proteins clustered using remote homology. NAR Genomics Bioinforma, 3
Thaden JT, Fowler VG, Sexton DJ, Anderson DJ (2016) Increasing Incidence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout the Southeastern United States. Infect Control Hosp Epidemiol 37:49–54
Turner D, Shkoporov AN, Lood C, Millard AD, Dutilh BE, Alfenas-Zerbini P, van Zyl LJ, Aziz RK, Oksanen HM, Poranen MM, Kropinski AM, Barylski J, Brister JR, Chanisvili N, Edwards RA, Enault F, Gillis A, Knezevic P, Krupovic M, Kurtböke I, Kushkina A, Lavigne R, Lehman S, Lobocka M, Moraru C, Moreno Switt A, Morozova V, Nakavuma J, Reyes Muñoz A, Rūmnieks J, Sarkar BL, Sullivan MB, Uchiyama J, Wittmann J, Yigang T, Adriaenssens EM (2023) Abolishment of morphology-based taxa and change to binomial species names: 2022 taxonomy update of the ICTV bacterial viruses subcommittee. Adv Virol 168:74
Tynecki P, Guziński A, Kazimierczak J, Jadczuk M, Dastych J, Onisko A (2020). PhageAI - Bacteriophage Life Cycle Recognition with Machine Learning and Natural Language Processing. https://doi.org/10.1101/2020.07.11.198606
Walker PJ, Siddell SG, Lefkowitz EJ, Mushegian AR, Dempsey DM, Dutilh BE, Harrach B, Harrison RL, Hendrickson RC, Junglen S, Knowles NJ, Kropinski AM, Krupovic M, Kuhn JH, Nibert M, Rubino L, Sabanadzovic S, Simmonds P, Varsani A, Zerbini FM, Davison AJ (2019) Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019). Arch Virol 164:2417–2429
Wittebole X, De Roock S, Opal SM (2014) A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5(1):226–235. https://doi.org/10.4161/viru.25991
Xu Y, Liu Y, Liu Y, Pei J, Yao S, Cheng C (2015) Bacteriophage Therapy against Enterobacteriaceae Virol Sin 30:11–18
Yosef I, Goren MG, Globus R, Molshanski-Mor S, Qimron U (2017) Extending the host range of bacteriophage particles for DNA transduction. Mol Cell 66(5):721–728.e3. https://doi.org/10.1016/j.molcel.2017.04.025
Yu G, Smith DK, Zhu H, Guan Y, Lam TT-Y (2017) ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol 8:28–36
Zhao J, Zhang Z, Tian C, Chen X, Hu L, Wei X, Li H, Lin W, Jiang A, Feng R, Yuan J, Yin Z, Zhao X (2019) Characterizing the biology of lytic bacteriophage vB_EaeM_phiEap-3 infecting multidrug-resistant Enterobacter aerogenes. Front Microbiol 10:420
Acknowledgements
We express our sincere gratitude to Prof. Dr. Krishna Das Manandhar, Head of the Central Department of Biotechnology at Tribhuvan University, for his unwavering support throughout the study. Additionally, we extend our heartfelt appreciation to Dr. Manoj Rajaure, Adhya’s Lab, Laboratory of Molecular Biology, NCI, NIH, whose expertise in phage genome analysis and NCBI submission provided invaluable guidance and support.
Funding
Open Access funding enabled and organized by CAUL and its Member Institutions This research was partially supported by the “PhD Fellowship and Research Support” awarded to GD by the University Grants Commission, Nepal (UGC-Nepal) (Award Numbers: PhD/73–74/S and T-07).
Author information
Authors and Affiliations
Contributions
Conceptualization and funding acquisition: GD, RM. Methodology, investigation: GD. Analysis and visualization: GD, RN, GH, GB. Supervision: RM. Writing – original draft: GD, RN. Writing – review & editing: GD, RN, GH, GB, SV. All authors revised the manuscript and approved the submitted version.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors declare no competing interests.
Limitations
We could not elucidate the mechanism underlying the ability of øEc_Makalu_002 and øEc_Makalu_003 to lyse K. pneumoniae (NK and K23) as this was beyond the scope of this project. Further research is required to elucidate the mechanism for inter-genus host lysis capability which may help us engineer synthetic phages with the ability to lyse wider hosts.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Dhungana, G., Nepal, R., Houtak, G. et al. Preclinical characterization and in silico safety assessment of three virulent bacteriophages targeting carbapenem-resistant uropathogenic Escherichia coli. Int Microbiol (2024). https://doi.org/10.1007/s10123-024-00508-8
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10123-024-00508-8